When President Obama announced the new Precision Medicine Initiative in January, he recognized the enormous potential of genomic research and the growing role of genomics in clinical care. Both genomic research and genomic medicine are loaded with challenging ethical, legal, and social issues. In a series of NIH-funded grants beginning in 2005, Prof. Susan Wolf has been leading work on the question of how and when should genomic research results and incidental findings be offered to research participants, patients, and families. More recently, she has collaborated with other NIH-funded investigators in the Clinical Sequencing Exploratory Research (CSER) Consortium to develop a new model of the ethics of translational genomics. That model envisions a central role for return of results in propelling progress from research to clinical integration of genomic sequencing. Prof. Wolf will illuminate these cutting-edge issues, analyze ongoing debates, and address the future of genomics in medicine and public health.
Check out the attached flyer for more information.